What if a prostate cancer patient could learn which anti-cancer treatments would work best for him without having to swallow a single pill or endure a single intravenous line or injection? Research involving the development of human organoid prostate models could have implications for how future therapy is guided for some of this population.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1Ho3lPn
No comments:
Post a Comment